Your session is about to expire
← Back to Search
Behavioral Intervention
MILC Application for Exclusive Breastfeeding (MILC Trial)
N/A
Waitlist Available
Led By Tony Ma, MS
Research Sponsored by Benten Technologies, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 month, 3 months and 6 months
Awards & highlights
No Placebo-Only Group
Summary
This trial aims to create a support platform called MILC to help low-income Hispanic women with breastfeeding. Research and testing will be used to develop and refine the platform for these women. The goal is to
Who is the study for?
This trial is for low-income Hispanic mothers who are currently breastfeeding or planning to breastfeed. It aims to help them overcome breastfeeding challenges using a mobile app called MILC, which offers professional and social support along with personalized education.
What is being tested?
The study is testing the effectiveness of the MILC application in promoting exclusive and any breastfeeding behaviors compared to usual care methods. The app provides a network of support tailored specifically for Hispanic women.
What are the potential side effects?
Since this trial involves the use of a mobile application rather than medication, there are no direct medical side effects. However, users may experience increased screen time or stress if technical issues arise.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1 month, 3 months and 6 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 month, 3 months and 6 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Any breastfeeding rate(EBF)
Exclusive breastfeeding
Secondary study objectives
Emergency department visit (Medical outcomes)
Infant weight (Medical outcomes)
Other study objectives
Acceptance and Adoption
Acculturation
BF history & attitudes questionnaire
+5 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Group I: Intervention group: MILC applicationExperimental Treatment1 Intervention
Eligible Hispanic participants in their third trimester will be recruited for the study. The intervention group will receive standard WIC services plus the MILC application.
Group II: Control Group: Usual CareExperimental Treatment1 Intervention
Participants in the control group will receive care as usual with standard breastfeeding services from the WIC program.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Usual care
2011
Completed Phase 4
~23770
Find a Location
Who is running the clinical trial?
Temple UniversityOTHER
316 Previous Clinical Trials
89,129 Total Patients Enrolled
National Institute on Minority Health and Health Disparities (NIMHD)NIH
444 Previous Clinical Trials
1,413,473 Total Patients Enrolled
Benten Technologies, Inc.Lead Sponsor
3 Previous Clinical Trials
704 Total Patients Enrolled
UConn HealthOTHER
215 Previous Clinical Trials
60,543 Total Patients Enrolled
RTI InternationalOTHER
197 Previous Clinical Trials
939,970 Total Patients Enrolled
Tony Ma, MSPrincipal InvestigatorBenten Technologies
2 Previous Clinical Trials
701 Total Patients Enrolled
Yukiko Washio, PhDPrincipal InvestigatorRTI International
2 Previous Clinical Trials
280 Total Patients Enrolled